Altimmune appoints life sciences industry veteran greg weaver as chief financial officer

Gaithersburg, md., nov. 11, 2024 (globe newswire) -- altimmune, inc. (nasdaq: alt), a clinical-stage biopharmaceutical company, today announced the appointment of greg weaver as chief financial officer (cfo), effective immediately. mr. weaver will lead the company's finance and accounting functions, including sec reporting and investor relations.
ALT Ratings Summary
ALT Quant Ranking